Shi Gao Liu
Nessuna posizione attualmente
Patrimonio netto: 4 M $ in data 31/03/2024
Profilo
Shi Gao Liu is the founder of two companies, Henlius Biopharmaceuticals, Inc. and Shanghai Henlius Biotech, Inc., both founded in 2009.
He held the title of President & Chief Executive Officer at Henlius Biopharmaceuticals, Inc. and Chief Executive Office & Executive Director at Shanghai Henlius Biotech, Inc. Dr. Liu received a doctorate degree from Purdue University in 1991.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
30/06/2023 | 2 410 695 ( 1.48% ) | 4 M $ | 31/03/2024 |
Precedenti posizioni note di Shi Gao Liu
Società | Posizione | Fine |
---|---|---|
SHANGHAI HENLIUS BIOTECH, INC. | Founder | 30/09/2020 |
Henlius Biopharmaceuticals, Inc.
Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Henlius Biopharmaceuticals, Inc. focuses on development and commercialization of mAb-based therapeutics biosimilars and biobetter for malignant tumors and auto-immune diseases. The company was founded by Scott Liu and Paul Liu in 2009 and is headquartered in Fremont, CA. | Chief Executive Officer | - |
Formazione di Shi Gao Liu
Purdue University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SHANGHAI HENLIUS BIOTECH, INC. | Health Technology |
Aziende private | 1 |
---|---|
Henlius Biopharmaceuticals, Inc.
Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Henlius Biopharmaceuticals, Inc. focuses on development and commercialization of mAb-based therapeutics biosimilars and biobetter for malignant tumors and auto-immune diseases. The company was founded by Scott Liu and Paul Liu in 2009 and is headquartered in Fremont, CA. | Health Technology |
- Borsa valori
- Insiders
- Shi Gao Liu